{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T07:51:46Z","timestamp":1726300306344},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00104-022-01595-x","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T09:02:53Z","timestamp":1649235773000},"page":"1107-1120","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Osteoporose: Diagnostik und Behandlung"],"prefix":"10.1007","volume":"93","author":[{"given":"Ulla","family":"Stumpf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Ladurner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Neuerburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"B\u00f6cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"1595_CR1","first-page":"52","volume":"110","author":"P Hadji","year":"2013","unstructured":"Hadji\u00a0P, Klein\u00a0S, Gothe\u00a0H et al (2013) Epidemiologie der osteoporose: Bone evaluation study: Eine analyse von Krankenkassen-Routinedaten. Dtsch Arztebl Int 110:52\u201357","journal-title":"Dtsch Arztebl Int"},{"key":"1595_CR2","unstructured":"WHO (1994) Study Group Assessment of fracture risk and its application to screening for postmenopausal osteoporosis"},{"key":"1595_CR3","unstructured":"Dachverband Osteologie e.\u202fV. (DVO) Entwurf f\u00fcr DVO-Leitlinien zur Therapie der Osteoporose (06.03.2009). Im Internet: www.dv-osteologie.de; Stand: 09.03.2009. Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei postmenopausalen Frauen. http:\/\/www.dv-osteologie.org. Zugriffsdatum: 26.03.2021"},{"key":"1595_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s00113-015-0076-x","volume":"118","author":"C Neuerburg","year":"2015","unstructured":"Neuerburg\u00a0C, Stumpf\u00a0U, Mutschler\u00a0W (2015) Osteoporose. Unfallchirurg 118:904. https:\/\/doi.org\/10.1007\/s00113-015-0076-x","journal-title":"Unfallchirurg"},{"key":"1595_CR5","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jamda.2020.09.038","volume":"22","author":"SA Welch","year":"2021","unstructured":"Welch\u00a0SA, Ward\u00a0RE, Beauchamp\u00a0MK, Leveille\u00a0SG, Travison\u00a0T, Bean\u00a0JF (2021) The Short Physical Performance Battery (SPPB): A quick and useful tool for fall risk stratification among older primary care patients. J Am Med Dir Assoc 22:1646\u20131651, https:\/\/doi.org\/10.1016\/j.jamda.2020.09.038","journal-title":"J Am Med Dir Assoc"},{"key":"1595_CR6","first-page":"196","volume":"87","author":"U Lichtenauer","year":"2020","unstructured":"Lichtenauer\u00a0U, Ladurner\u00a0R, Reincke\u00a0M (2020) Chir Prax 87:196\u2013206","journal-title":"Chir Prax"},{"key":"1595_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40520-019-01432-y","volume":"32","author":"JA Kanis","year":"2020","unstructured":"Kanis\u00a0JA, Harvey\u00a0NC, Johansson\u00a0H et\u00a0al (2020) A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res 32:187\u2013196","journal-title":"Aging Clin Exp Res"},{"key":"1595_CR8","unstructured":"Primary Care Use of FRAX\u00ae: Absolute Fracture Risk Assessment in Postmenopausal Women and Older Men"},{"key":"1595_CR9","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20352","author":"S Ferrari","year":"2020","unstructured":"Ferrari\u00a0S, Lippuner\u00a0K, Lamy\u00a0O et\u00a0al (2020) 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Med Wkly. https:\/\/doi.org\/10.4414\/smw.2020.20352","journal-title":"Swiss Med Wkly"},{"key":"1595_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040848","author":"AM Keppler","year":"2021","unstructured":"Keppler\u00a0AM, Kraus\u00a0M, Blaschke\u00a0M et\u00a0al (2021) Reduced awareness for osteoporosis in distal radius fracture patients compared to patients with proximal femur fractures. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10040848","journal-title":"J Clin Med"},{"key":"1595_CR11","unstructured":"Schiegnitz\u00a0E, Al-Nawas\u00a0B, Hoefert\u00a0S et\u00a0al (2018) Antiresorptiva-assoziierte Kiefernekrosen (AR-ONJ) S3-Leitlinie, 2018"},{"key":"1595_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00198-015-3415-4","volume":"27","author":"W Brozek","year":"2016","unstructured":"Brozek\u00a0W, Reichardt\u00a0B, Zwerina\u00a0J et\u00a0al (2016) Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Osteoporos Int 27:387\u2013396. https:\/\/doi.org\/10.1007\/s00198-015-3415-4","journal-title":"Osteoporos Int"},{"key":"1595_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15360288.2016.1276993","volume":"31","author":"BJ Flores-Robles","year":"2017","unstructured":"Flores-Robles\u00a0BJ, Sanz-Sanz\u00a0J, Sanabria-Sanchinel\u00a0AA et al (2017) Zoledronic acid treatment in primary bone marrow edema syndrome. J\u00a0Pain Palliat Care Pharmacother 31:52\u201356","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1595_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/jbmr.2393","volume":"30","author":"D Bliuc","year":"2015","unstructured":"Bliuc\u00a0D, Alarkawi\u00a0D, Nguyen\u00a0TV et\u00a0al (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the dubbo osteoporosis epidemiology study. J\u00a0Bone Miner Res 30:637\u2013646","journal-title":"J Bone Miner Res"},{"key":"1595_CR15","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00198-015-3164-4","volume":"26","author":"P Hadji","year":"2015","unstructured":"Hadji\u00a0P, Papaioannou\u00a0N, Gielen\u00a0E et al (2015) Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a\u00a0European non-interventional study. Osteoporos Int 26:2479\u20132489. https:\/\/doi.org\/10.1007\/s00198-015-3164-4","journal-title":"Osteoporos Int"},{"key":"1595_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-017-0351-2","volume":"12","author":"A Fahrleitner-Pammer","year":"2017","unstructured":"Fahrleitner-Pammer\u00a0A, Papaioannou\u00a0N, Gielen\u00a0E et al (2017) Factors associated with high 24-month persistence with denosumab: results of a\u00a0real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium. Arch Osteoporos 12:58. https:\/\/doi.org\/10.1007\/s11657-017-0351-2","journal-title":"Arch Osteoporos"},{"key":"1595_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","volume":"386","author":"BZ Leder","year":"2015","unstructured":"Leder\u00a0BZ, Tsai\u00a0JN, Uihlein\u00a0AV et al (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a\u00a0randomised controlled trial. Lancet 386:1147\u20131155 (https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673615611205)","journal-title":"Lancet"},{"key":"1595_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jbmr.3622","volume":"34","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki\u00a0EM, Dinavahi\u00a0RV, Lazaretti-Castro\u00a0M et al (2019) One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study. J\u00a0Bone Miner Res 34:419\u2013428. https:\/\/doi.org\/10.1002\/jbmr.3622","journal-title":"J Bone Miner Res"},{"key":"1595_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00113-019-00705-5","author":"E Hesse","year":"2019","unstructured":"Hesse\u00a0E, B\u00f6cker\u00a0W, Kammerlander\u00a0C et\u00a0al (2019) Etablierung von Frakturnetzwerken in Deutschland. Unfallchirurg. https:\/\/doi.org\/10.1007\/s00113-019-00705-5","journal-title":"Unfallchirurg"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-022-01595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-022-01595-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-022-01595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T15:02:52Z","timestamp":1666623772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-022-01595-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1007\/s00104-022-01595-x","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"14 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>U.\u00a0Stumpf<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung im Rahmen des Studienganges \u201eMolekulare Medizin\u201c der Ludwig-Maximilians-Universit\u00e4t (LMU) M\u00fcnchen.\u00a0\u2013 Vortragst\u00e4tigkeit: Fa. Amgen, Fa. Eli Lilly.\u00a0\u2013 Advisory Board: Fa Alexion, Fa. Eli Lilly.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin f\u00fcr Orthop\u00e4die und Unfallchirurgie, Klinik f\u00fcr Allgemeine, Unfall- und Wiederherstellungschirurgie der LMU M\u00fcnchen. <b>M.\u00a0Kraus<\/b>: A.\u00a0Finanzielle Interessen: M.\u00a0Kraus gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter, Klinikum der Universit\u00e4t M\u00fcnchen LMU, Klinik f\u00fcr Allgemeine, Unfall- und Wiederherstellungschirurgie. <b>R.\u00a0Ladurner<\/b>: A.\u00a0Finanzielle Interessen: R.\u00a0Ladurner gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Seit 01.01.2022: Chefarzt der Klinik f\u00fcr Allgemein\u2011, Viszeral- und Thoraxchirurgie, Martha Maria M\u00fcnchen. <b>C.\u00a0Neuerburg<\/b>: A.\u00a0Finanzielle Interessen: C.\u00a0Neuerburg gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leitender Oberarzt Klinik f\u00fcr Orthop\u00e4die und Unfallchirurgie, Muskuloskelettales Universit\u00e4tszentrum M\u00fcnchen (MUM), LMU Klinikum | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Unfallchirurgie (DGU), Deutsche Gesellschaft f\u00fcr Orthop\u00e4die und Unfallchirurgie (DGOU), Deutsche Gesellschaft f\u00fcr Orthop\u00e4die und Orthop\u00e4dische Chirurgie (DGOOC), Arbeitsgemeinschaft Osteosynthese (AO) Trauma, Deutsche Akademie der osteologischen rheumatologischen Wissenschaften (DAdorW). <b>W.\u00a0B\u00f6cker<\/b>: A.\u00a0Finanzielle Interessen: Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Vortr\u00e4ge zum Thema Fracture Liaison Service f\u00fcr Amgen und UCB auf Symposien.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztlicher Direktor der Muskuloskelettalen Universit\u00e4tszentrum M\u00fcnchen LMU Klinikum der Ludwig-Maximilians-Universit\u00e4t (LMU) Campus Innenstadt und Gro\u00dfhadern, Mitglied T\u00dcV-S\u00fcd Medizinscher Beirat, Mitglied der Leitlinien-Kommission \u201eOsteoporose\u201c des Dachverbands der Osteologischen Gesellschaften (DVO), Leiter AG Osteologie der Deutschen Gesellschaft f\u00fcr Unfallchirurgie, Sprecher des Bayerischen Cluster Medizintechnik sowie Vorsitz des Expertengremiums Medizintechnik Bayern des Bayerischen Ministerium f\u00fcr Wirtschaft, Beirat AO Trauma Deutschland | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Unfallchirurgie (DGU).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}